July 24, 2019 | PixCell Medical Technologies Ltd. Booth #814
HemoScreen’s™ Viscoelastic Focusing; A breakthrough in cellular analysis for Hematology and other critical POC assays.
Anaheim Convention Center, Anaheim CA. Pixcell’s Hanan Ben-Asher will present in the Disruptive Technology Award competition beginning at 4:30 PM PT, August 5th in Ballroom ABC. Mr. Ben-Asher’s presentation will feature the Hematology application for the Hemoscreen™, a single, compact platform bringing the most critical of laboratory assays to the Point of Care.
Hanan Ben-Asher, Operations and Business Development, is an experienced business executive with expertise in multidisciplinary research and development and a strong background in medical device development. Prior to his position at PixCell Hanan served as R&D manager at Medoc Advanced Medical Systems. He holds a B.Sc. (cum laude) in Biomedical Engineering and an MBA, both from the Technion Israel Institute of Technology.
PixCell Medical Technologies develops, produces, and markets portable medical diagnostic products for point of care testing. PixCell’s products are based on its innovative Viscoelastic Focusing (VEF) technology and single use cartridges that enable rapid, accurate and simple blood sampling and analysis. Results are displayed within minutes in an easily readable format. PixCell’s mission is to develop assays currently restricted to the laboratory more accessible for near patient testing, easy to use and affordable.
PixCell Medical Technologies is a privately held Israeli company developing cell-based point of care (POC) diagnostics devices. PixCell’s first product, HemoScreen™, is a point of care complete blood count (CBC) system. It is CE marked, FDA cleared, and is currently being marketed in Europe.
Visit us at Booth # 814
